Cencora, Inc. (LON:0HF3)
London flag London · Delayed Price · Currency is GBP · Price in USD
369.23
-7.43 (-1.97%)
At close: Nov 26, 2025

Cencora Revenue

In the fiscal year ending September 30, 2025, Cencora had annual revenue of $321.33B USD with 9.31% growth. Cencora had revenue of $83.73B in the quarter ending September 30, 2025, with 5.92% growth.

Revenue
$321.33B
Revenue Growth
+9.31%
P/S Ratio
0.23
Revenue / Employee
$6.30M
Employees
51,000
Market Cap
54.03B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 2025321.33B27.37B9.31%
Sep 30, 2024293.96B31.79B12.12%
Sep 30, 2023262.17B23.59B9.89%
Sep 30, 2022238.59B24.60B11.50%
Sep 30, 2021213.99B24.09B12.69%
Sep 30, 2020189.89B10.30B5.74%
Sep 30, 2019179.59B11.65B6.94%
Sep 30, 2018167.94B14.80B9.66%
Sep 30, 2017153.14B6.29B4.29%
Sep 30, 2016146.85B10.89B8.01%
Sep 30, 2015135.96B16.39B13.71%
Sep 30, 2014119.57B31.61B35.94%
Sep 30, 201387.96B9.88B12.65%
Sep 30, 201278.08B-614.85M-0.78%
Sep 30, 201178.70B919.20M1.18%
Sep 30, 201077.78B6.02B8.38%
Sep 30, 200971.76B1.57B2.24%
Sep 30, 200870.19B8.92B14.56%
Sep 30, 200761.27B--
Sep 30, 2006---
Sep 30, 200550.01B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca43.24B
GSK plc32.17B
Haleon11.02B
Smith & Nephew4.33B
Hikma Pharmaceuticals2.35B
ConvaTec Group1.72B
Spire Healthcare Group1.55B
Genus672.80M
Revenue Rankings